These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7901023)

  • 41. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the molecular variance at the phenylalanine hydroxylase (PAH) locus.
    Degioanni A; Darlu P
    Eur J Hum Genet; 1994; 2(3):166-76. PubMed ID: 7834276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.
    Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C
    Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Classical phenylketonuria in Bulgaria: RFLP haplotypes and frequency of the major mutations.
    Kalaydjieva L; Dworniczak B; Aulehla-Scholz C; Kremensky I; Bronzova J; Eigel A; Horst J
    J Med Genet; 1990 Dec; 27(12):742-5. PubMed ID: 1981599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders.
    Ledley FD; Levy HL; Woo SL
    N Engl J Med; 1986 May; 314(20):1276-80. PubMed ID: 3702929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
    Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N
    Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotype-phenotype correlations in phenylketonuria.
    Trefz FK; Burgard P; König T; Goebel-Schreiner B; Lichter-Konecki U; Konecki D; Schmidt E; Schmidt H; Bickel H
    Clin Chim Acta; 1993 Jul; 217(1):15-21. PubMed ID: 8222278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia.
    Weglage J; Pietsch M; Feldmann R; Koch HG; Zschocke J; Hoffmann G; Muntau-Heger A; Denecke J; Guldberg P; Güttler F; Möller H; Wendel U; Ullrich K; Harms E
    Pediatr Res; 2001 Apr; 49(4):532-6. PubMed ID: 11264437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.
    Weinstein M; Eisensmith RC; Abadie V; Avigad S; Lyonnet S; Schwartz G; Munnich A; Woo SL; Shiloh Y
    Hum Genet; 1993 Feb; 90(6):645-9. PubMed ID: 8095248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation spectrum of phenylketonuria in Syrian population: genotype-phenotype correlation.
    Murad H; Dabboul A; Moassas F; Alasmar D; Al-Achkar W
    Gene; 2013 Oct; 528(2):241-7. PubMed ID: 23856132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two distinct mutations at a single BamHI site in phenylketonuria.
    Melle D; Verelst P; Rey F; Berthelon M; François B; Munnich A; Lyonnet S
    J Med Genet; 1991 Jan; 28(1):38-40. PubMed ID: 1671881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular basis of phenylketonuria in Venezuela: presence of two novel null mutations.
    De Lucca M; Pérez B; Desviat LR; Ugarte M
    Hum Mutat; 1998; 11(5):354-9. PubMed ID: 9600453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Origins of hyperphenylalaninemia in Israel.
    Kleiman S; Avigad S; Vanagaite L; Shmuelevitz A; David M; Eisensmith RC; Brand N; Schwartz G; Rey F; Munnich A; Woo SL; Shiloh Y
    Eur J Hum Genet; 1994; 2(1):24-34. PubMed ID: 7913865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients.
    Svensson E; von Döbeln U; Eisensmith RC; Hagenfeldt L; Woo SL
    Eur J Pediatr; 1993 Feb; 152(2):132-9. PubMed ID: 8444221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular genetic aspects of phenylketonuria (PKU)].
    Giltay JC; van Hoef AM; de Weger R; Duran M; Berger R; Beemer FA
    Tijdschr Kindergeneeskd; 1991 Jun; 59(3):77-80. PubMed ID: 1677790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of the IVS-10nt546 mutation in 44 Turkish phenylketonuria patients.
    Ozgüç M; Ozalp I; Coşkun T; Yilmaz E; Erdem H; Ayter S
    Turk J Pediatr; 1993; 35(1):11-4. PubMed ID: 7901929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations of the phenylalanine hydroxylase (PAH) gene in Brazilian patients with phenylketonuria.
    Acosta A; Silva W; Carvalho T; Gomes M; Zago M
    Hum Mutat; 2001 Feb; 17(2):122-30. PubMed ID: 11180595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.
    Leuzzi V; Trasimeni G; Gualdi GF; Antonozzi I
    J Inherit Metab Dis; 1995; 18(5):624-34. PubMed ID: 8598645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.